BHGE - General Electric's $14 Billion Profit On BioPharma Sale
Source: GE Healthcare
General Electric's BioPharma Sale - The Untold Story
There has been much news and many opinions published about the benefits to General Electric (GE) from the sale of its BioPharma business to Danaher (DHR). Here is one of mine - Feb. 28, 2019 - "GE: Culp Brings Simplification And Value Creation, Share Price Will See $20 Before $10":
GE's Culp Now Has Greater Freedom To Concentrate On Working On, And In, And Growing The Remaining Business Segments
The cash from the BioPharma sale to Danaher relieves GE of